1 | metabolites | 3,658 |
2 | metabolite | 2,054 |
3 | intermediates | 520 |
4 | proteome | 335 |
5 | pools | 289 |
6 | isomer | 280 |
7 | adduct | 221 |
8 | glucuronide | 162 |
9 | lactone | 161 |
10 | volatiles | 153 |
11 | aglycone | 128 |
12 | enantiomer | 93 |
13 | glucoside | 88 |
14 | glucosides | 77 |
15 | adulterants | 76 |
16 | congener | 74 |
17 | metabolome | 71 |
18 | sulfates | 47 |
19 | glucuronides | 46 |
20 | aglycones | 44 |
21 | commuting | 42 |
22 | oxylipins | 41 |
23 | paralogs | 35 |
24 | alkene | 33 |
25 | compression-decompression | 33 |
26 | end-product | 33 |
27 | epimer | 31 |
28 | stereoisomer | 30 |
29 | diester | 29 |
30 | monocomponents | 27 |
31 | predecessor | 24 |
32 | catabolites | 23 |
33 | photoproducts | 23 |
34 | tautomer | 22 |
35 | diradical | 21 |
36 | equivalent/g | 18 |
37 | hydroxylases | 18 |
38 | beta-subunit | 17 |
39 | diols | 16 |
40 | naphthalenes | 15 |
41 | peptidome | 15 |
42 | nanobody | 13 |
43 | regioisomer | 13 |
44 | aglycon | 12 |
45 | counterfeits | 12 |
46 | secoiridoids | 11 |
47 | ethoxylates | 10 |
48 | 3-epimerase | 9 |
49 | 4-oh | 9 |
50 | flavonolignans | 9 |
51 | isotopomers | 9 |
52 | dienophiles | 7 |
53 | cycloadduct | 6 |
54 | d-isomer | 6 |
55 | non-toxicity | 6 |
56 | 3-glucoside | 5 |
57 | 7-methyl | 5 |
58 | abrotanoides | 5 |
59 | apoferritin | 5 |
60 | commuters | 5 |
61 | immunodeviation | 5 |
62 | isotopologue | 5 |
63 | opposites | 5 |
64 | π-system | 5 |
65 | 18:1t | 4 |
66 | 6-sulfo | 4 |
67 | ac-5-asa | 4 |
68 | astringency | 4 |
69 | diacid | 4 |
70 | diglycoside | 4 |
71 | lys/mcal | 4 |
72 | neoepitope | 4 |
73 | non-integrin | 4 |
74 | proteinic | 4 |
75 | vasotocin | 4 |
76 | 1h-1,2,3- | 3 |
77 | 3-o-β-glucoside-7-o-α-rhamnoside | 3 |
78 | 5f7ggc | 3 |
79 | 7-glucoside | 3 |
80 | antipode | 3 |
81 | biosynthesis-related | 3 |
82 | catenanes | 3 |
83 | deuteride | 3 |
84 | ecl1 | 3 |
85 | halocline | 3 |
86 | malononitriles | 3 |
87 | metabolite/precursor | 3 |
88 | ndh-1 | 3 |
89 | nematicide | 3 |
90 | nucleocapsids | 3 |
91 | o-glucuronide | 3 |
92 | osi-420 | 3 |
93 | physiotherapies | 3 |
94 | sulphides | 3 |
95 | 2-oxoacids | 2 |
96 | 5-hydroxylated | 2 |
97 | acetylenecarboxylates | 2 |
98 | activation/inactivation | 2 |
99 | agonist/antagonists | 2 |
100 | alkylamide | 2 |
101 | alleys | 2 |
102 | arylations | 2 |
103 | atropo-diastereomer | 2 |
104 | bleomycin-sensitive | 2 |
105 | c151 | 2 |
106 | chromenotacrine | 2 |
107 | conjugase | 2 |
108 | diglucuronide | 2 |
109 | emanations | 2 |
110 | evens | 2 |
111 | hepatocarcinogen | 2 |
112 | hyperphos-phorylation | 2 |
113 | lh-hcg | 2 |
114 | malonyl-glucoside | 2 |
115 | microcarriers | 2 |
116 | monoimid | 2 |
117 | monosulfates | 2 |
118 | motherland | 2 |
119 | ndl-pcb | 2 |
120 | o-desmethyl | 2 |
121 | regio-isomer | 2 |
122 | thio-conjugates | 2 |
123 | -3.5-g-d-tween-80 | 1 |
124 | 10-monohydroxy | 1 |
125 | 14-oh-metabolite | 1 |
126 | 15-17-year-olds | 1 |
127 | 1h-pyrrol-3-aminium | 1 |
128 | 2-acylamino | 1 |
129 | 29/31-kda | 1 |
130 | 3,3-dimethyl | 1 |
131 | 3-o-α-rhamnoside | 1 |
132 | 3-substituted-3-amino-2-oxindoles | 1 |
133 | 4-monooxygenases | 1 |
134 | 5,5-diethyl | 1 |
135 | 7-o-α-rhamnoside | 1 |
136 | 8-c-apiosyl-glucoside | 1 |
137 | abz-sulphoxide | 1 |
138 | affliates | 1 |
139 | ageing-concept | 1 |
140 | aglicone | 1 |
141 | angle-reproduction | 1 |
142 | antagonist-il-4δ2 | 1 |
143 | antienzymic | 1 |
144 | apolar-α-tocopherol | 1 |
145 | arabinofuranosides | 1 |
146 | arginyl-fructosyl-glucose | 1 |
147 | artemisoides | 1 |
148 | bent-knee | 1 |
149 | binding- | 1 |
150 | binol-derived | 1 |
151 | bio-ingredient | 1 |
152 | bonded-form | 1 |
153 | bromines | 1 |
154 | c5-epimer | 1 |
155 | c6-methylated | 1 |
156 | cipionate | 1 |
157 | control/reference | 1 |
158 | cycle-specificity | 1 |
159 | d-threo | 1 |
160 | d1-tyr161 | 1 |
161 | derviative | 1 |
162 | des-controlled | 1 |
163 | dialuminum | 1 |
164 | dichain | 1 |
165 | dihaloaromatic | 1 |
166 | dimmer | 1 |
167 | dosage-forms | 1 |
168 | embryo/embryo | 1 |
169 | energogenic | 1 |
170 | etoposides | 1 |
171 | galacto-analog | 1 |
172 | glucoside-derived | 1 |
173 | hydroxy-metabolites | 1 |
174 | hydroxymethylsulfonate | 1 |
175 | incidence.however | 1 |
176 | ingredient/100 | 1 |
177 | isotope-coded | 1 |
178 | junb-containing | 1 |
179 | l-alpha-ketoglutarate | 1 |
180 | life-impact | 1 |
181 | longhui | 1 |
182 | manitestations | 1 |
183 | modification-dependent | 1 |
184 | movement/mobilizations | 1 |
185 | multi-ethnicity | 1 |
186 | multiactivities | 1 |
187 | multitherapeutic | 1 |
188 | n'-arylmethylidene-2- | 1 |
189 | n-deuterated | 1 |
190 | n-mono-demethylated | 1 |
191 | neu2en | 1 |
192 | non-isomorphous | 1 |
193 | nonutilizable | 1 |
194 | o-arabinoside | 1 |
195 | o-o-h | 1 |
196 | oh/h | 1 |
197 | oit/placebo | 1 |
198 | orgin | 1 |
199 | paav-antisense | 1 |
200 | pentoside | 1 |
201 | post-orchidectomy | 1 |
202 | proatherogenicity | 1 |
203 | propanediol-utilization | 1 |
204 | pseudoindoxyl | 1 |
205 | pyridylimine-based | 1 |
206 | r-alpha | 1 |
207 | repairation | 1 |
208 | s0→s4 | 1 |
209 | self-shortening | 1 |
210 | sequelae-namely | 1 |
211 | slit/placebo | 1 |
212 | sobriquet | 1 |
213 | template-the | 1 |
214 | topo-active | 1 |
215 | trans-pyrazolidines | 1 |
216 | trans-trans | 1 |
217 | truest | 1 |
218 | variey | 1 |
219 | vca-dependent | 1 |
220 | vinylsilyl | 1 |
221 | xylanase-hydrolyzate | 1 |
222 | α-flupenthixol | 1 |
223 | π-extension | 1 |
1 | -3.5-g-d-tween-80 | 1 |
2 | 10-monohydroxy | 1 |
3 | 14-oh-metabolite | 1 |
4 | 15-17-year-olds | 1 |
5 | 18:1t | 4 |
6 | 1h-1,2,3- | 3 |
7 | 1h-pyrrol-3-aminium | 1 |
8 | 2-acylamino | 1 |
9 | 2-oxoacids | 2 |
10 | 29/31-kda | 1 |
11 | 3,3-dimethyl | 1 |
12 | 3-epimerase | 9 |
13 | 3-glucoside | 5 |
14 | 3-o-α-rhamnoside | 1 |
15 | 3-o-β-glucoside-7-o-α-rhamnoside | 3 |
16 | 3-substituted-3-amino-2-oxindoles | 1 |
17 | 4-monooxygenases | 1 |
18 | 4-oh | 9 |
19 | 5,5-diethyl | 1 |
20 | 5-hydroxylated | 2 |
21 | 5f7ggc | 3 |
22 | 6-sulfo | 4 |
23 | 7-glucoside | 3 |
24 | 7-methyl | 5 |
25 | 7-o-α-rhamnoside | 1 |
26 | 8-c-apiosyl-glucoside | 1 |
27 | abrotanoides | 5 |
28 | abz-sulphoxide | 1 |
29 | ac-5-asa | 4 |
30 | acetylenecarboxylates | 2 |
31 | activation/inactivation | 2 |
32 | adduct | 221 |
33 | adulterants | 76 |
34 | affliates | 1 |
35 | ageing-concept | 1 |
36 | aglicone | 1 |
37 | aglycon | 12 |
38 | aglycone | 128 |
39 | aglycones | 44 |
40 | agonist/antagonists | 2 |
41 | alkene | 33 |
42 | alkylamide | 2 |
43 | alleys | 2 |
44 | angle-reproduction | 1 |
45 | antagonist-il-4δ2 | 1 |
46 | antienzymic | 1 |
47 | antipode | 3 |
48 | apoferritin | 5 |
49 | apolar-α-tocopherol | 1 |
50 | arabinofuranosides | 1 |
51 | arginyl-fructosyl-glucose | 1 |
52 | artemisoides | 1 |
53 | arylations | 2 |
54 | astringency | 4 |
55 | atropo-diastereomer | 2 |
56 | bent-knee | 1 |
57 | beta-subunit | 17 |
58 | binding- | 1 |
59 | binol-derived | 1 |
60 | bio-ingredient | 1 |
61 | biosynthesis-related | 3 |
62 | bleomycin-sensitive | 2 |
63 | bonded-form | 1 |
64 | bromines | 1 |
65 | c151 | 2 |
66 | c5-epimer | 1 |
67 | c6-methylated | 1 |
68 | catabolites | 23 |
69 | catenanes | 3 |
70 | chromenotacrine | 2 |
71 | cipionate | 1 |
72 | commuters | 5 |
73 | commuting | 42 |
74 | compression-decompression | 33 |
75 | congener | 74 |
76 | conjugase | 2 |
77 | control/reference | 1 |
78 | counterfeits | 12 |
79 | cycle-specificity | 1 |
80 | cycloadduct | 6 |
81 | d-isomer | 6 |
82 | d-threo | 1 |
83 | d1-tyr161 | 1 |
84 | derviative | 1 |
85 | des-controlled | 1 |
86 | deuteride | 3 |
87 | diacid | 4 |
88 | dialuminum | 1 |
89 | dichain | 1 |
90 | dienophiles | 7 |
91 | diester | 29 |
92 | diglucuronide | 2 |
93 | diglycoside | 4 |
94 | dihaloaromatic | 1 |
95 | dimmer | 1 |
96 | diols | 16 |
97 | diradical | 21 |
98 | dosage-forms | 1 |
99 | ecl1 | 3 |
100 | emanations | 2 |
101 | embryo/embryo | 1 |
102 | enantiomer | 93 |
103 | end-product | 33 |
104 | energogenic | 1 |
105 | epimer | 31 |
106 | equivalent/g | 18 |
107 | ethoxylates | 10 |
108 | etoposides | 1 |
109 | evens | 2 |
110 | flavonolignans | 9 |
111 | galacto-analog | 1 |
112 | glucoside | 88 |
113 | glucoside-derived | 1 |
114 | glucosides | 77 |
115 | glucuronide | 162 |
116 | glucuronides | 46 |
117 | halocline | 3 |
118 | hepatocarcinogen | 2 |
119 | hydroxy-metabolites | 1 |
120 | hydroxylases | 18 |
121 | hydroxymethylsulfonate | 1 |
122 | hyperphos-phorylation | 2 |
123 | immunodeviation | 5 |
124 | incidence.however | 1 |
125 | ingredient/100 | 1 |
126 | intermediates | 520 |
127 | isomer | 280 |
128 | isotope-coded | 1 |
129 | isotopologue | 5 |
130 | isotopomers | 9 |
131 | junb-containing | 1 |
132 | l-alpha-ketoglutarate | 1 |
133 | lactone | 161 |
134 | lh-hcg | 2 |
135 | life-impact | 1 |
136 | longhui | 1 |
137 | lys/mcal | 4 |
138 | malononitriles | 3 |
139 | malonyl-glucoside | 2 |
140 | manitestations | 1 |
141 | metabolite | 2,054 |
142 | metabolite/precursor | 3 |
143 | metabolites | 3,658 |
144 | metabolome | 71 |
145 | microcarriers | 2 |
146 | modification-dependent | 1 |
147 | monocomponents | 27 |
148 | monoimid | 2 |
149 | monosulfates | 2 |
150 | motherland | 2 |
151 | movement/mobilizations | 1 |
152 | multi-ethnicity | 1 |
153 | multiactivities | 1 |
154 | multitherapeutic | 1 |
155 | n'-arylmethylidene-2- | 1 |
156 | n-deuterated | 1 |
157 | n-mono-demethylated | 1 |
158 | nanobody | 13 |
159 | naphthalenes | 15 |
160 | ndh-1 | 3 |
161 | ndl-pcb | 2 |
162 | nematicide | 3 |
163 | neoepitope | 4 |
164 | neu2en | 1 |
165 | non-integrin | 4 |
166 | non-isomorphous | 1 |
167 | non-toxicity | 6 |
168 | nonutilizable | 1 |
169 | nucleocapsids | 3 |
170 | o-arabinoside | 1 |
171 | o-desmethyl | 2 |
172 | o-glucuronide | 3 |
173 | o-o-h | 1 |
174 | oh/h | 1 |
175 | oit/placebo | 1 |
176 | opposites | 5 |
177 | orgin | 1 |
178 | osi-420 | 3 |
179 | oxylipins | 41 |
180 | paav-antisense | 1 |
181 | paralogs | 35 |
182 | pentoside | 1 |
183 | peptidome | 15 |
184 | photoproducts | 23 |
185 | physiotherapies | 3 |
186 | pools | 289 |
187 | post-orchidectomy | 1 |
188 | predecessor | 24 |
189 | proatherogenicity | 1 |
190 | propanediol-utilization | 1 |
191 | proteinic | 4 |
192 | proteome | 335 |
193 | pseudoindoxyl | 1 |
194 | pyridylimine-based | 1 |
195 | r-alpha | 1 |
196 | regio-isomer | 2 |
197 | regioisomer | 13 |
198 | repairation | 1 |
199 | s0→s4 | 1 |
200 | secoiridoids | 11 |
201 | self-shortening | 1 |
202 | sequelae-namely | 1 |
203 | slit/placebo | 1 |
204 | sobriquet | 1 |
205 | stereoisomer | 30 |
206 | sulfates | 47 |
207 | sulphides | 3 |
208 | tautomer | 22 |
209 | template-the | 1 |
210 | thio-conjugates | 2 |
211 | topo-active | 1 |
212 | trans-pyrazolidines | 1 |
213 | trans-trans | 1 |
214 | truest | 1 |
215 | variey | 1 |
216 | vasotocin | 4 |
217 | vca-dependent | 1 |
218 | vinylsilyl | 1 |
219 | volatiles | 153 |
220 | xylanase-hydrolyzate | 1 |
221 | α-flupenthixol | 1 |
222 | π-extension | 1 |
223 | π-system | 5 |
1 | n'-arylmethylidene-2- | 1 |
2 | 1h-1,2,3- | 3 |
3 | binding- | 1 |
4 | ingredient/100 | 1 |
5 | osi-420 | 3 |
6 | -3.5-g-d-tween-80 | 1 |
7 | ndh-1 | 3 |
8 | c151 | 2 |
9 | d1-tyr161 | 1 |
10 | ecl1 | 3 |
11 | antagonist-il-4δ2 | 1 |
12 | s0→s4 | 1 |
13 | 29/31-kda | 1 |
14 | r-alpha | 1 |
15 | ac-5-asa | 4 |
16 | ndl-pcb | 2 |
17 | 5f7ggc | 3 |
18 | antienzymic | 1 |
19 | energogenic | 1 |
20 | proteinic | 4 |
21 | dihaloaromatic | 1 |
22 | multitherapeutic | 1 |
23 | isotope-coded | 1 |
24 | des-controlled | 1 |
25 | pyridylimine-based | 1 |
26 | biosynthesis-related | 3 |
27 | c6-methylated | 1 |
28 | n-mono-demethylated | 1 |
29 | 5-hydroxylated | 2 |
30 | n-deuterated | 1 |
31 | glucoside-derived | 1 |
32 | binol-derived | 1 |
33 | diacid | 4 |
34 | monoimid | 2 |
35 | motherland | 2 |
36 | control/reference | 1 |
37 | nematicide | 3 |
38 | alkylamide | 2 |
39 | glucuronide | 162 |
40 | o-glucuronide | 3 |
41 | diglucuronide | 2 |
42 | deuteride | 3 |
43 | glucoside | 88 |
44 | 3-glucoside | 5 |
45 | 7-glucoside | 3 |
46 | malonyl-glucoside | 2 |
47 | 8-c-apiosyl-glucoside | 1 |
48 | diglycoside | 4 |
49 | o-arabinoside | 1 |
50 | 3-o-α-rhamnoside | 1 |
51 | 7-o-α-rhamnoside | 1 |
52 | 3-o-β-glucoside-7-o-α-rhamnoside | 3 |
53 | pentoside | 1 |
54 | abz-sulphoxide | 1 |
55 | antipode | 3 |
56 | bent-knee | 1 |
57 | template-the | 1 |
58 | nonutilizable | 1 |
59 | peptidome | 15 |
60 | proteome | 335 |
61 | metabolome | 71 |
62 | alkene | 33 |
63 | halocline | 3 |
64 | chromenotacrine | 2 |
65 | aglicone | 1 |
66 | aglycone | 128 |
67 | lactone | 161 |
68 | neoepitope | 4 |
69 | conjugase | 2 |
70 | 3-epimerase | 9 |
71 | paav-antisense | 1 |
72 | arginyl-fructosyl-glucose | 1 |
73 | hydroxymethylsulfonate | 1 |
74 | cipionate | 1 |
75 | l-alpha-ketoglutarate | 1 |
76 | xylanase-hydrolyzate | 1 |
77 | metabolite | 2,054 |
78 | 14-oh-metabolite | 1 |
79 | isotopologue | 5 |
80 | derviative | 1 |
81 | topo-active | 1 |
82 | bleomycin-sensitive | 2 |
83 | equivalent/g | 18 |
84 | lh-hcg | 2 |
85 | self-shortening | 1 |
86 | junb-containing | 1 |
87 | commuting | 42 |
88 | galacto-analog | 1 |
89 | o-o-h | 1 |
90 | oh/h | 1 |
91 | 4-oh | 9 |
92 | longhui | 1 |
93 | diradical | 21 |
94 | lys/mcal | 4 |
95 | apolar-α-tocopherol | 1 |
96 | α-flupenthixol | 1 |
97 | 5,5-diethyl | 1 |
98 | 7-methyl | 5 |
99 | 3,3-dimethyl | 1 |
100 | o-desmethyl | 2 |
101 | vinylsilyl | 1 |
102 | pseudoindoxyl | 1 |
103 | π-system | 5 |
104 | bonded-form | 1 |
105 | 1h-pyrrol-3-aminium | 1 |
106 | dialuminum | 1 |
107 | neu2en | 1 |
108 | hepatocarcinogen | 2 |
109 | dichain | 1 |
110 | vasotocin | 4 |
111 | orgin | 1 |
112 | non-integrin | 4 |
113 | apoferritin | 5 |
114 | aglycon | 12 |
115 | π-extension | 1 |
116 | compression-decompression | 33 |
117 | immunodeviation | 5 |
118 | hyperphos-phorylation | 2 |
119 | repairation | 1 |
120 | activation/inactivation | 2 |
121 | propanediol-utilization | 1 |
122 | angle-reproduction | 1 |
123 | slit/placebo | 1 |
124 | oit/placebo | 1 |
125 | d-threo | 1 |
126 | 6-sulfo | 4 |
127 | 2-acylamino | 1 |
128 | embryo/embryo | 1 |
129 | epimer | 31 |
130 | c5-epimer | 1 |
131 | dimmer | 1 |
132 | atropo-diastereomer | 2 |
133 | enantiomer | 93 |
134 | isomer | 280 |
135 | d-isomer | 6 |
136 | regio-isomer | 2 |
137 | stereoisomer | 30 |
138 | regioisomer | 13 |
139 | tautomer | 22 |
140 | congener | 74 |
141 | diester | 29 |
142 | incidence.however | 1 |
143 | metabolite/precursor | 3 |
144 | predecessor | 24 |
145 | 2-oxoacids | 2 |
146 | secoiridoids | 11 |
147 | nucleocapsids | 3 |
148 | 15-17-year-olds | 1 |
149 | sulphides | 3 |
150 | glucuronides | 46 |
151 | abrotanoides | 5 |
152 | artemisoides | 1 |
153 | glucosides | 77 |
154 | arabinofuranosides | 1 |
155 | etoposides | 1 |
156 | physiotherapies | 3 |
157 | multiactivities | 1 |
158 | dienophiles | 7 |
159 | malononitriles | 3 |
160 | volatiles | 153 |
161 | 3-substituted-3-amino-2-oxindoles | 1 |
162 | catenanes | 3 |
163 | naphthalenes | 15 |
164 | trans-pyrazolidines | 1 |
165 | bromines | 1 |
166 | aglycones | 44 |
167 | hydroxylases | 18 |
168 | 4-monooxygenases | 1 |
169 | sulfates | 47 |
170 | monosulfates | 2 |
171 | thio-conjugates | 2 |
172 | intermediates | 520 |
173 | affliates | 1 |
174 | acetylenecarboxylates | 2 |
175 | ethoxylates | 10 |
176 | catabolites | 23 |
177 | metabolites | 3,658 |
178 | hydroxy-metabolites | 1 |
179 | opposites | 5 |
180 | paralogs | 35 |
181 | diols | 16 |
182 | pools | 289 |
183 | dosage-forms | 1 |
184 | flavonolignans | 9 |
185 | trans-trans | 1 |
186 | evens | 2 |
187 | oxylipins | 41 |
188 | arylations | 2 |
189 | emanations | 2 |
190 | manitestations | 1 |
191 | movement/mobilizations | 1 |
192 | microcarriers | 2 |
193 | isotopomers | 9 |
194 | commuters | 5 |
195 | photoproducts | 23 |
196 | counterfeits | 12 |
197 | adulterants | 76 |
198 | monocomponents | 27 |
199 | agonist/antagonists | 2 |
200 | non-isomorphous | 1 |
201 | alleys | 2 |
202 | 18:1t | 4 |
203 | life-impact | 1 |
204 | adduct | 221 |
205 | cycloadduct | 6 |
206 | end-product | 33 |
207 | sobriquet | 1 |
208 | beta-subunit | 17 |
209 | vca-dependent | 1 |
210 | modification-dependent | 1 |
211 | bio-ingredient | 1 |
212 | ageing-concept | 1 |
213 | truest | 1 |
214 | astringency | 4 |
215 | nanobody | 13 |
216 | variey | 1 |
217 | sequelae-namely | 1 |
218 | post-orchidectomy | 1 |
219 | cycle-specificity | 1 |
220 | proatherogenicity | 1 |
221 | multi-ethnicity | 1 |
222 | non-toxicity | 6 |
223 | 10-monohydroxy | 1 |